CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 79642-79701 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"Ribavirin and palivizumab inhibited infection of the cells.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T482","span":{"begin":0,"end":59},"obj":"Sentence"},{"id":"T35703","span":{"begin":0,"end":59},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T482","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T35703","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T191","span":{"begin":0,"end":59},"obj":"Sentence"}],"attributes":[{"subj":"T191","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T383","span":{"begin":36,"end":45},"obj":"Disease"}],"attributes":[{"id":"A383","pred":"mondo_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"subj":"T383","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecb2","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec9893"},{"id":"CORD-19-PD-MONDO","color":"#93a7ec"}]}]}}